AIDS WEEKLY Plus - August 2002Important note: Information in this article was accurate in August 2002. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

Healthcare Access: AIDS drug prices drop 54% in Latin AmericaCaribbean

AIDSWEEKLY Plus; August 12, 2002
Staff Medical Writer


NewsRx --Prices of antiretroviral drugs to treat HIV/AIDS dropped up to 54% last year in Latin America and the Caribbean countries as a result of agreements between ministries of health and drug manufacturersaccording to a survey by the Pan American Health Organization (PAHO).

But there are also wide differences between the countries surveyedwith some countries paying up to 10 times more for the same treatmentthe survey revealed. Antiretroviral drugs have been shown to improve health statusproductivity and quality and length of life of people living with HIV/AIDS.

The PAHO survey compared the prices of drugs purchased in May 2001 and May 2002 by the ministries of health of 14 countries in Latin America and the Caribbean. To calculate the annual cost of treating a person living with AIDSPAHO selected two of the most common combinations of antiretroviral therapies. On average the reductions for 3TC/ZDV+NVP were 25% (from $3701 to $2746). For 3TC/ZDV+EFV the prices decreased 54% (from $5506 to $2499).

These prices do not reflect further reductions that some countries were able to negotiate with the companies since then. According to information received by PAHO after the surveyin some Caribbean and Central American countries the cost to provide drugs to AIDS patients is now around $1100 per year. The Caribbean has the second highest prevalence rate of HIV/AIDS in the worldafter sub-Saharan Africa.

Until nownegotiations were carried out on a country-by-country basis and some governments were more successful in obtaining antiretroviral price reductions than others. In Haitifor instancethe cost of 3TC/ZDV+EFV dropped from $21,489 to $1606 in the period surveyed. Another country that managed to reduce prices significantly was Brazilwhere the cost of 3TC/ZDV+NVP fell from $1408 to $635the lowest in the region of the Americas. For the same combinationhoweversome countries were paying more than $6000.

Under the framework of the WHO/UNAIDS Accelerated Access InitiativePAHO is supporting countries in the region in their efforts to increase access to comprehensive HIV care and supportincluding antiretroviral medicines.

As drug prices drop and health systems improvesignificant progress is being made in these areas. Even with greatly reduced drug priceshowevermany countries cannot afford to provide antiretroviral drugs to all those in need. It is estimated that at least 475,000 people need antiretroviral treatment in Latin America and the Caribbean(25% of the 1.9 million people living with HIV/AIDS in the region)but only 170,000 currently have access to the drugsthe majority of them in Brazil.

The world AIDS epidemic "has reached alarming proportions," according to Dr. George Alleynedirector of PAHO. "In the Region of the Americas1 in every 200 persons between 15 and 49 years of age is HIV-infected. In the Caribbean1 in every 50 people has the infectionand it is clear that the incidence of HIV among men continues to increase worldwide."

This article was prepared by AIDS Weekly editors from staff and other reports.

020812
AW020806


Copyright © 2002 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.